X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs J.B.CHEMICALS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER J.B.CHEMICALS PFIZER/
J.B.CHEMICALS
 
P/E (TTM) x 28.8 15.9 181.0% View Chart
P/BV x 4.6 2.5 182.0% View Chart
Dividend Yield % 0.7 0.2 459.3%  

Financials

 PFIZER   J.B.CHEMICALS
EQUITY SHARE DATA
    PFIZER
Mar-16
J.B.CHEMICALS
Mar-16
PFIZER/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,724318 856.3%   
Low Rs1,611200 807.5%   
Sales per share (Unadj.) Rs440.9148.0 297.9%  
Earnings per share (Unadj.) Rs48.719.1 255.2%  
Cash flow per share (Unadj.) Rs75.823.9 316.4%  
Dividends per share (Unadj.) Rs15.000.50 3,000.0%  
Dividend yield (eoy) %0.70.2 358.2%  
Book value per share (Unadj.) Rs462.9128.9 359.0%  
Shares outstanding (eoy) m45.7584.82 53.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.7 281.1%   
Avg P/E ratio x44.513.6 328.2%  
P/CF ratio (eoy) x28.610.8 264.7%  
Price / Book Value ratio x4.72.0 233.3%  
Dividend payout %30.82.6 1,175.7%   
Avg Mkt Cap Rs m99,16321,951 451.7%   
No. of employees `0002.92.7 105.7%   
Total wages/salary Rs m2,7581,841 149.8%   
Avg. sales/employee Rs Th6,981.74,590.9 152.1%   
Avg. wages/employee Rs Th954.5673.4 141.7%   
Avg. net profit/employee Rs Th771.1592.1 130.2%   
INCOME DATA
Net Sales Rs m20,17012,551 160.7%  
Other income Rs m857542 158.3%   
Total revenues Rs m21,02813,093 160.6%   
Gross profit Rs m4,3102,055 209.8%  
Depreciation Rs m1,239412 300.4%   
Interest Rs m596 5.4%   
Profit before tax Rs m3,9232,088 187.9%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m990-   
Tax Rs m1,794469 382.5%   
Profit after tax Rs m2,2281,619 137.6%  
Gross profit margin %21.416.4 130.5%  
Effective tax rate %45.722.5 203.6%   
Net profit margin %11.012.9 85.6%  
BALANCE SHEET DATA
Current assets Rs m16,2997,778 209.6%   
Current liabilities Rs m7,5944,358 174.2%   
Net working cap to sales %43.227.2 158.4%  
Current ratio x2.11.8 120.3%  
Inventory Days Days6555 119.4%  
Debtors Days Days2680 32.2%  
Net fixed assets Rs m8,6225,713 150.9%   
Share capital Rs m458170 269.8%   
"Free" reserves Rs m20,72210,547 196.5%   
Net worth Rs m21,18010,937 193.6%   
Long term debt Rs m250-   
Total assets Rs m29,13715,574 187.1%  
Interest coverage x755.522.8 3,310.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.8 85.9%   
Return on assets %7.711.0 69.6%  
Return on equity %10.514.8 71.1%  
Return on capital %19.020.0 95.1%  
Exports to sales %0.148.7 0.1%   
Imports to sales %17.57.1 246.9%   
Exports (fob) Rs m126,115 0.2%   
Imports (cif) Rs m3,526889 396.7%   
Fx inflow Rs m526,169 0.8%   
Fx outflow Rs m1401,285 10.9%   
Net fx Rs m-884,884 -1.8%   
CASH FLOW
From Operations Rs m3,4361,397 246.0%  
From Investments Rs m-6,991-320 2,182.6%  
From Financial Activity Rs m-619-1,196 51.7%  
Net Cashflow Rs m-4,174-102 4,079.7%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 63.9 0.3 21,300.0%  
Indian inst/Mut Fund % 7.5 3.4 221.2%  
FIIs % 4.9 3.9 125.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 37.0 64.1%  
Shareholders   85,207 30,437 279.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Jan 19, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS